Live News EQUITY FLASH L impact Sep 28, 2026, 04:35 AM UTC Morepen Laboratories submits first U.S. ANDA for sitagliptin tablets USP in three strengths The filing covers three strengths of sitagliptin tablets USP. MORL.NS SquawkNews Newsroom